Valley Brook Capital Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
WJWM
Valley Brook Capital Group's IDXX Position: Q2 2026 in Review
Valley Brook Capital Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 425 shares worth $224K. The position accounts for 0.13% of the portfolio, ranked #108.
Valley Brook Capital Group first reported a position in IDXX in Q4 2020 and has held it in 21 quarters since. The position peaked at $439K in Q2 2023. 658 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Valley Brook Capital Group held 425 shares of Idexx Laboratories worth $224K as of Q2 2026.
- Valley Brook Capital Group left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.13% of Valley Brook Capital Group's portfolio in Q2 2026, its #108 holding.
- Valley Brook Capital Group first reported a position in Idexx Laboratories in Q4 2020 and has held it in 21 quarters since.
- Valley Brook Capital Group's Idexx Laboratories position peaked at $439K in Q2 2023.
- 658 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.